GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED
Company number 08283289
- Company Overview for GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED (08283289)
- Filing history for GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED (08283289)
- People for GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED (08283289)
- More for GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED (08283289)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
03 Mar 2023 | TM01 | Termination of appointment of Jerome Charles Maurice Andries as a director on 1 March 2023 | |
03 Mar 2023 | AP01 | Appointment of Ms Jill Anderson as a director on 1 March 2023 | |
03 Nov 2022 | AP01 | Appointment of Dr Ziba Shamsi as a director on 28 October 2022 | |
02 Nov 2022 | TM01 | Termination of appointment of Kate Sophie Priestman as a director on 28 October 2022 | |
13 Sep 2022 | CS01 | Confirmation statement made on 10 September 2022 with no updates | |
15 Aug 2022 | AA | Full accounts made up to 31 December 2021 | |
28 Sep 2021 | CS01 | Confirmation statement made on 10 September 2021 with no updates | |
27 Sep 2021 | AA | Full accounts made up to 31 December 2020 | |
09 Oct 2020 | AA | Full accounts made up to 31 December 2019 | |
24 Sep 2020 | CS01 | Confirmation statement made on 10 September 2020 with no updates | |
24 Sep 2019 | AA | Full accounts made up to 31 December 2018 | |
10 Sep 2019 | CS01 | Confirmation statement made on 10 September 2019 with no updates | |
03 Sep 2019 | AP01 | Appointment of Mr James Russell Wheatcroft as a director on 1 July 2019 | |
07 May 2019 | TM01 | Termination of appointment of Simon Paul Dingemans as a director on 1 May 2019 | |
03 Dec 2018 | CS01 | Confirmation statement made on 6 November 2018 with no updates | |
06 Oct 2018 | AA | Full accounts made up to 31 December 2017 | |
05 Mar 2018 | PSC02 | Notification of Glaxosmithkline Finance Plc as a person with significant control on 6 April 2016 | |
05 Mar 2018 | PSC05 | Change of details for Glaxo Group Limited as a person with significant control on 6 April 2016 | |
30 Jan 2018 | CH01 | Director's details changed for Mr Jerome Charles Maurice Andries on 14 November 2017 | |
17 Nov 2017 | CS01 | Confirmation statement made on 6 November 2017 with updates | |
17 Nov 2017 | AP01 | Appointment of Mr Jerome Charles Maurice Andries as a director on 1 October 2017 | |
16 Nov 2017 | TM01 | Termination of appointment of Luigi Felice La Corte as a director on 30 September 2017 | |
28 Sep 2017 | AA | Full accounts made up to 31 December 2016 | |
07 Jan 2017 | AP01 | Appointment of Kate Sophie Priestman as a director on 9 December 2016 | |
21 Dec 2016 | SH01 |
Statement of capital following an allotment of shares on 16 December 2016
|